{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:33:34Z","timestamp":1761744814435,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00404-018-4830-5","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:23:24Z","timestamp":1529886204000},"page":"521-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tocolysis with the \u03b22-sympathomimetic fenoterol does not increase the occurrence of infantile hemangioma in preterm and term infants"],"prefix":"10.1007","volume":"298","author":[{"given":"Hannes","family":"Hudalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Karmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Wallwiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Fluhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Freis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Maul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Strowitzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"P\u00f6schl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-0694","authenticated-orcid":false,"given":"Ruben-J.","family":"Kuon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"issue":"Suppl 1","key":"4830_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","volume":"10","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Cousens S, Chou D et al (2013) Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 10(Suppl 1):S2","journal-title":"Reprod Health"},{"issue":"1","key":"4830_CR2","first-page":"1\u201369","volume":"62","author":"JA Martin","year":"2013","unstructured":"Martin JA, Hamilton BE, Ventura SJ et al (2013) Births: final data for 2011. Natl Vital Stat Rep 62(1):1\u201369\u20131\u201372","journal-title":"Natl Vital Stat Rep"},{"key":"4830_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2471\/BLT.08.062554","volume":"88","author":"S Beck","year":"2010","unstructured":"Beck S, Wojdyla D, Say L et al (2010) The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 88:31\u201338. \n                    https:\/\/doi.org\/10.2471\/BLT.08.062554","journal-title":"Bull World Health Organ"},{"key":"4830_CR4","doi-asserted-by":"publisher","first-page":"e6226","DOI":"10.1136\/bmj.e6226","volume":"345","author":"DM Haas","year":"2012","unstructured":"Haas DM, Caldwell DM, Kirkpatrick P et al (2012) Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 345:e6226","journal-title":"BMJ"},{"key":"4830_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/AOG.0b013e318199924a","volume":"113","author":"DM Haas","year":"2009","unstructured":"Haas DM, Imperiale TF, Kirkpatrick PR et al (2009) Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol 113:585\u2013594. \n                    https:\/\/doi.org\/10.1097\/AOG.0b013e318199924a","journal-title":"Obstet Gynecol"},{"key":"4830_CR6","doi-asserted-by":"publisher","first-page":"b744","DOI":"10.1136\/bmj.b744","volume":"338","author":"R Heus de","year":"2009","unstructured":"de Heus R, Mol BW, Erwich J-JHM et al (2009) Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ 338:b744","journal-title":"BMJ"},{"key":"4830_CR7","doi-asserted-by":"publisher","first-page":"F108","DOI":"10.1136\/archdischild-2011-301030","volume":"98","author":"M Mayer","year":"2013","unstructured":"Mayer M, Minichmayr A, Klement F et al (2013) Tocolysis with the \u03b2-2-sympathomimetic hexoprenaline increases occurrence of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed 98:F108\u2013F111. \n                    https:\/\/doi.org\/10.1136\/archdischild-2011-301030","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"4830_CR8","unstructured":"Frieden IJ, Haggstrom AN, Drolet BA et al (2005) Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7\u20139, 2005, Bethesda, Maryland, USA. In: Pediatr Dermatol, pp 383\u2013406"},{"key":"4830_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Harper JI, Hoeger PH (2017) Infantile haemangioma. Lancet 390:85\u201394. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)00645-0","journal-title":"Lancet"},{"key":"4830_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1056\/NEJM199907153410307","volume":"341","author":"BA Drolet","year":"1999","unstructured":"Drolet BA, Esterly NB, Frieden IJ (1999) Hemangiomas in children. N Engl J Med 341:173\u2013181. \n                    https:\/\/doi.org\/10.1056\/NEJM199907153410307","journal-title":"N Engl J Med"},{"key":"4830_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jpeds.2008.05.043","volume":"153","author":"BA Drolet","year":"2008","unstructured":"Drolet BA, Swanson EA, Frieden IJ, Hemangioma Investigator Group (2008) Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 153:712\u2013715e1. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2008.05.043","journal-title":"J Pediatr"},{"key":"4830_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1525-1470.2008.00626.x","volume":"25","author":"C Kilcline","year":"2008","unstructured":"Kilcline C, Frieden IJ (2008) Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 25:168\u2013173. \n                    https:\/\/doi.org\/10.1111\/j.1525-1470.2008.00626.x","journal-title":"Pediatr Dermatol"},{"key":"4830_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","volume":"390","author":"MD Dclalz","year":"2017","unstructured":"Dclalz MD, Pjih MD, Pphh MD (2017) Infantile haemangioma. Lancet 390:85\u201394. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)00645-0","journal-title":"Lancet"},{"key":"4830_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/bdr2.1023","volume":"109","author":"CJF Smith","year":"2017","unstructured":"Smith CJF, Friedlander SF, Guma M et al (2017) Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res 109:809\u2013815. \n                    https:\/\/doi.org\/10.1002\/bdr2.1023","journal-title":"Birth Defects Res"},{"key":"4830_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jid.2016.10.047","volume":"137","author":"MK Hunjan","year":"2017","unstructured":"Hunjan MK, Schoch JJ, Anderson KR et al (2017) Prenatal risk factors for infantile hemangioma development. J Invest Dermatol 137:954\u2013957. \n                    https:\/\/doi.org\/10.1016\/j.jid.2016.10.047","journal-title":"J Invest Dermatol"},{"key":"4830_CR16","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1056\/NEJMc086443","volume":"359","author":"EC Siegfried","year":"2008","unstructured":"Siegfried EC, Keenan WJ, Al-Jureidini S (2008) More on propranolol for hemangiomas of infancy. N Engl J Med 359:2846. \n                    https:\/\/doi.org\/10.1056\/nejmc086443\n                    \n                   (author reply 2846\u20137)","journal-title":"N Engl J Med"},{"key":"4830_CR17","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2009","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, la Roque de ED, Hubiche T et al (2009) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649\u20132651. \n                    https:\/\/doi.org\/10.1056\/nejmc0708819","journal-title":"N Engl J Med"},{"key":"4830_CR18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2133.2009.09597.x","volume":"162","author":"F Manunza","year":"2010","unstructured":"Manunza F, Syed S, Laguda B et al (2010) Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 162:466\u2013468. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09597.x","journal-title":"Br J Dermatol"},{"key":"4830_CR19","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1111\/pde.12850","volume":"33","author":"MM Woody","year":"2016","unstructured":"Woody MM, Levy ML, Weinfeld AB (2016) Propranolol for preoperative management of a large infantile hemangioma. Pediatr Dermatol 33:e198\u2013e200. \n                    https:\/\/doi.org\/10.1111\/pde.12850","journal-title":"Pediatr Dermatol"},{"key":"4830_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MOO.0000000000000170","volume":"23","author":"JA Ames","year":"2015","unstructured":"Ames JA, Sykes JM (2015) Current trends in medical management of infantile hemangioma. Curr Opin Otolaryngol Head Neck Surg 23:286\u2013291. \n                    https:\/\/doi.org\/10.1097\/MOO.0000000000000170","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"4830_CR21","first-page":"548","volume":"2007","author":"SN Murphy","year":"2007","unstructured":"Murphy SN, Mendis M, Hackett K et al (2007) Architecture of the open-source clinical research chart from Informatics for Integrating Biology and the Bedside. AMIA Annu Symp Proc 2007:548\u2013552","journal-title":"AMIA Annu Symp Proc"},{"key":"4830_CR22","first-page":"1060","volume":"205","author":"C Karmen","year":"2014","unstructured":"Karmen C, Ganzinger M, Kohl CD et al (2014) A framework for integrating heterogeneous clinical data for a disease area into a central data warehouse. Stud Health Technol Inform 205:1060\u20131064","journal-title":"Stud Health Technol Inform"},{"key":"4830_CR23","unstructured":"Kawabata H, Tran M, Hines P (2004) Using SAS\u00ae to match cases for case control studies. SUGI 29. Princeton, New Jersey, 173\u201329"},{"key":"4830_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.phrs.2009.05.005","volume":"60","author":"B Annabi","year":"2009","unstructured":"Annabi B, Lachambre M-P, Plouffe K et al (2009) Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res 60:438\u2013445. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2009.05.005","journal-title":"Pharmacol Res"},{"key":"4830_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","volume":"163","author":"CH Storch","year":"2010","unstructured":"Storch CH, Hoeger PH (2010) Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163:269\u2013274. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09848.x","journal-title":"Br J Dermatol"},{"key":"4830_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/AOG.0b013e31825189dc","volume":"119","author":"KE Murphy","year":"2012","unstructured":"Murphy KE, Willan AR, Hannah ME et al (2012) Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol 119:917\u2013923. \n                    https:\/\/doi.org\/10.1097\/AOG.0b013e31825189dc","journal-title":"Obstet Gynecol"},{"key":"4830_CR27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1542\/peds.2006-0413","volume":"118","author":"AN Haggstrom","year":"2006","unstructured":"Haggstrom AN, Drolet BA, Baselga E et al (2006) Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118:882\u2013887. \n                    https:\/\/doi.org\/10.1542\/peds.2006-0413","journal-title":"Pediatrics"},{"key":"4830_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/pde.12781","volume":"33","author":"MF Greco","year":"2016","unstructured":"Greco MF, Frieden IJ, Drolet BA et al (2016) Infantile hemangiomas in twins: a prospective cohort study. Pediatr Dermatol 33:178\u2013183. \n                    https:\/\/doi.org\/10.1111\/pde.12781","journal-title":"Pediatr Dermatol"},{"key":"4830_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/bjd.12804","volume":"170","author":"A Munden","year":"2014","unstructured":"Munden A, Butschek R, Tom WL et al (2014) Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol 170:907\u2013913. \n                    https:\/\/doi.org\/10.1111\/bjd.12804","journal-title":"Br J Dermatol"},{"key":"4830_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1525-1470.2011.01568.x","volume":"28","author":"P Dickison","year":"2011","unstructured":"Dickison P, Christou E, Wargon O (2011) A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 28:663\u2013669. \n                    https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01568.x","journal-title":"Pediatr Dermatol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-018-4830-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4830-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4830-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T08:44:49Z","timestamp":1561452289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-018-4830-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4830"],"URL":"https:\/\/doi.org\/10.1007\/s00404-018-4830-5","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"type":"print","value":"0932-0067"},{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"assertion":[{"value":"3 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The study was approved by the Heidelberg University institutional review board (Ethikkommission der Medizinischen Fakult\u00e4t Heidelberg, Alte Glockengie\u00dferei 11\/1, 69115 Heidelberg, Germany, IRB number: S-094\/2013). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Requirement for inform consent has been waived by the Heidelberg University institutional review board (Ethikkommission der Medizinischen Fakult\u00e4t Heidelberg, IRB number: S-094\/2013) due to the retrospective nature of the study and pseudonymization of data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}